Table 1.
Baseline characteristics and IBS-related summary measures of randomized patients.
| Baseline information | Intervention group (n = 32) | Control group (n = 32) | P value |
|---|---|---|---|
| Mean age (years), mean ± s.d. | 32.8 ± 9.7 | 35.7 ± 9.1 | 0.23 |
| Females, n (%) | 19 (59.37%) | 20 (62.5%) | 0.47 |
| BMI (kg/m2), mean ± s.d. | 23.1 ± 2.9 | 23.4 ± 3.2 | 0.58 |
| IBS disease duration (years), n (%) | |||
| <1 | 9 (28.12) | 12 (37.5) | |
| 1-5 | 15 (46.87) | 13 (40.62) | |
| >5 | 8 (25) | 7 (21.87) | |
| IBS subtype by predominant bowel habit, n (%) | |||
| IBS-D | 10 (31.2) | 13 (40.6) | |
| IBS-C | 8 (25) | 7 (21.8) | |
| IBS-M/U | 14 (43.7) | 12 (37.5) | |
IBS: irritable bowel syndrome; IBS-SSS: IBS Symptom Severity Scale; IBS-D: diarrhea-predominant IBS; IBS-C: constipation-predominant IBS; IBS-M/U: IBS with mixed symptoms/unsubtyped IBS; s.d.: standard deviation.